ARTICLE | Management Tracks
Plus: Barbara Handelin named co-CEO of Transformative Biotech, and updates from Zephyr AI, Venatorx, Glen Clova and more
By Richard Guy, Biopharma Analyst, and Gunjan Ohri, Data Content Analyst
May 16, 2024 10:32 PM UTC
Radiopharmaceuticals company Lantheus Holdings Inc. (NASDAQ:LNTH) named Jeffrey Humphrey as CMO and Jean-Claude Provost as CSO. Humphrey was CEO at Radd Pharmaceuticals Inc., and CMO at Magenta Therapeutics Inc. and Constellation Pharmaceuticals Inc.; Provost joined Lantheus as interim CMO in April 2022.
Transformative Biotech LLC named Barbara Handelin as co-CEO and a director. Handelin, who will share the CEO role with co-founder Russ Hullet, was CEO at Audacity Therapeutics PBC. She is also CEO of The 90/10 Institute, which she founded. …
- SEO Powered Content & PR Distribution. Get Amplified Today.
- PlatoData.Network Vertical Generative Ai. Empower Yourself. Access Here.
- PlatoAiStream. Web3 Intelligence. Knowledge Amplified. Access Here.
- PlatoESG. Carbon, CleanTech, Energy, Environment, Solar, Waste Management. Access Here.
- PlatoHealth. Biotech and Clinical Trials Intelligence. Access Here.
- Source: https://www.biocentury.com/article/652450/new-cmo-cso-at-lantheus